期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Asparaginase-associated pancreatitis in chemotherapytreated pediatric patients:a five-year retrospective study
1
作者 Chen-xi Liu Yun-yu Zhang +10 位作者 Qiu-shi Yang Shu-hong Shen Jing Chen Yan-jing Tang Chang-cheng Chen Zhuo Wang Bi-ru Li Juan Qian Ying Wang wen-ting hu Bo-tao Ning 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2022年第4期313-321,共9页
Asparaginase(Asp)represents a key agent in induction remission for acute lymphoblastic leukemia(ALL)and certain subtypes of non-Hodgkin lymphoma(NHL).By catalyzing the hydrolysis of extracellular asparagine,thus deple... Asparaginase(Asp)represents a key agent in induction remission for acute lymphoblastic leukemia(ALL)and certain subtypes of non-Hodgkin lymphoma(NHL).By catalyzing the hydrolysis of extracellular asparagine,thus depleting the level of plasma asparagine necessary for the growth of leukemic lymphoblasts,Asp can inhibit leukemic lymphoblast protein synthesis and lead to subsequent apoptosis with little myelosuppression.[1]This will achieve anti-leukemia efficacy,and promote the remission of leukemia.[2]A previous study showed that an Asp-containing regimen could significantly increase the event-free survival rate(71%vs.31%).[3]A previous study showed that those who completed the Asp regimen had a higher 5-year event-free survival rate(90%)than those who were unable to tolerate toxicity and quitted the treatment(73%).[4] 展开更多
关键词 REGIMEN ACUTE PANCREATITIS
下载PDF
Traditional Chinese herbal medicine plus triple therapy in treating Helicobacter pylori-induced chronic atrophic gastritis: a meta-analysis and cumulative meta-analysis
2
作者 Kai Xiong Ting-hui Yue +3 位作者 Tao Yang wen-ting hu Jia Deng Tian-bao Xiao 《Gastroenterology & Hepatology Research》 2022年第1期1-10,共10页
Objectives:To evaluate the benefits of traditional Chinese herbal medicine(TCHM)plus triple therapy(TT)in the management of Helicobacter pylori(H.pylori)-induced chronic atrophic gastritis(CAG).Methods:A comprehensive... Objectives:To evaluate the benefits of traditional Chinese herbal medicine(TCHM)plus triple therapy(TT)in the management of Helicobacter pylori(H.pylori)-induced chronic atrophic gastritis(CAG).Methods:A comprehensive access and electronic database search were carried out from inception to June 2020.Prospective randomized trials(TCHM plus TT vs.TT)were selected to assess the eradication rate of H.pylori(ER of H.pylori),clinical symptom relief rate(SRR),treatment-related adverse reactions(TRAR)and 95%confidence intervals(CI)in the meta-analysis and cumulative meta-analysis(CMA).Meta-regression analysis was used to analyze heterogeneity between studies and publication bias.Results:33 studies contained 3,226 participants were included.Compared with the TT group,TCHM plus TT group showed a significantly higher ER of H.pylori(OR=4.14,95%CI:3.21-5.35;P=0.000)and SRR(OR=4.50,95%CI:3.59-5.64).Meanwhile,the TRAR of TCHM plus TT remedy was significantly lower than TT monopoly(RR=0.43,95%CI:0.29-0.64;P=0.000).The results of the CMA,sorted by publication year,duration of treatment,and sample size,confirmed that combined treatment remedy was superior to TT monopoly in respect of ER of H.pylori and SRR.Conclusions:The present study obtained reliable and convincing evidence suggesting that TCHM plus TT remedy was efficacious and safe in treating H.pylori-induced CAG. 展开更多
关键词 traditional Chinese herbal medicine triple therapy helicobacter pylori chronic atrophic gastritis META-ANALYSIS cumulative meta-analysis
下载PDF
基于开环反应构建新型还原响应型支化聚赖氨酸基因载体 被引量:3
3
作者 陈艺铭 祁宇 +3 位作者 胡文婷 郑迪 俞丙然 徐福建 《高分子学报》 SCIE CAS CSCD 北大核心 2019年第6期602-612,共11页
通过'一锅法'开环反应构建了一种含有双硫键的还原响应型可降解支化聚赖氨酸基因载体(SS-HP).同时通过相似的方法合成了不含双硫键的支化聚赖氨酸基因载体(CC-HP)作为对照.聚阳离子/pDNA复合物的水合粒径和电位通过动态光散射... 通过'一锅法'开环反应构建了一种含有双硫键的还原响应型可降解支化聚赖氨酸基因载体(SS-HP).同时通过相似的方法合成了不含双硫键的支化聚赖氨酸基因载体(CC-HP)作为对照.聚阳离子/pDNA复合物的水合粒径和电位通过动态光散射仪测定,其在还原性环境中的降解情况通过凝胶阻滞电泳、原子力显微镜测试评价. SS-HP和CC-HP的体外转染能力及细胞毒性通过荧光素酶报告基因和MTT法在脑胶质瘤C6和肝癌HepG2细胞中测定.癌细胞中过量表达的谷胱甘肽能够使SS-HP在细胞内降解,加速pDNA的释放,使该载体有良好的基因转染能力.同时,载体的可降解性以及由开环反应给载体引入的大量羟基,使载体有较低的细胞毒性. KillerRed蛋白是一种在可见光照射下能产生单线态氧的红色荧光蛋白.使用SS-HP携载pKillerRed (pKR)质粒进行体外光动力抗癌评价. SS-HP/pKR转染C6细胞后能成功表达出KillerRed蛋白,光照后可以促进肿瘤细胞的凋亡. 展开更多
关键词 还原响应 生物可降解 支化聚合物 基因载体
原文传递
MicroRNA-543 in Systemic Diseases and Possible Applications in Gynecologic Tumors
4
作者 Yan-Ran Sheng wen-ting hu +3 位作者 Chun-Yan Wei Yu-Kai Liu Yu-Yin Liu Xiao-Yong Zhu 《Reproductive and Developmental Medicine》 CSCD 2021年第2期107-118,共12页
In recent years,an increasing number of young women have been diagnosed with cancer,including some nulliparous women.Therefore,many young patients with early-stage cancer desire to preserve fertility after cytotoxic o... In recent years,an increasing number of young women have been diagnosed with cancer,including some nulliparous women.Therefore,many young patients with early-stage cancer desire to preserve fertility after cytotoxic oncological treatments.It is important to develop a multidisciplinary approach to achieve the best outcomes for each patient.On the other hand,there has been a sharp increase in microRNAs(miRNAs)as potential biomarkers for the diagnosis,prognosis,and evaluation of treatment efficacy of several diseases.MiR-543 has been reported to affect the pathogenesis and progression of diseases via complex mechanisms.Understanding the regulatory role of miR-543 may aid comprehension of the pathogenesis and treatment of a broad range of diseases.Therefore,we provide an overview of the biogenesis,function,and role of miR-543 in various systems.These results shed light on the anticancer and endometrial protection role of miR-543 in young patients with gynecologic tumors and highlight the clinical potential of miR-543-based applications and related challenges. 展开更多
关键词 Endometrial Receptivity Gynecological Oncology MicroRNA-543 Pathway Target
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部